Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme GlobeNewswire August 13, 2025 First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic […]

Restart IL Innovation Conference to Spotlight Startups in AI, Medtech, Defense (Dual-Use), Proptech and Cyber Industries The international conference of visionary founders and leading investors will take place in Palo Alto on August 27th GlobeNewswire August 13, 2025 Palo Alto, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) — A premier showcase of cutting-edge innovation will be

Media Advisory: MADD Canada Honours Victims of Alcohol or Drug-Related Crashes at Manitoba Memorial Monument GlobeNewswire August 13, 2025 WEST ST. PAUL, Manitoba, Aug. 13, 2025 (GLOBE NEWSWIRE) — MADD Canada will host a ceremony to honour victims killed or injured in crashes involving alcohol, cannabis and/or other drugs. The ceremony will take place at

Clene to Present at the Emerging Growth Conference GlobeNewswire August 13, 2025 SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS)

Solo Brands, Inc. to Present and Host 1×1 Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 27, 2025 GlobeNewswire August 13, 2025 GRAPEVINE, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) — Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru)

New Myriad Genetics Survey Uncovers Women Fear Screenings–But Feel Reassured by the Results Cancer Risk Survey shows that more than half of women at high-risk for hereditary cancer would feel “empowered” by more advanced screening like genetic testing GlobeNewswire August 13, 2025 SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ:

Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire August 13, 2025 Continuing to enroll nAMD patients in a Phase 1 trial of TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina; initial clinical data is expected

Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets(TM). GlobeNewswire August 13, 2025 Delray Beach, FL, Aug. 13, 2025 (GLOBE NEWSWIRE) — Stringent quality standards, technological innovation, and global healthcare expansion accelerate market growth The global clinical microbiology market, valued at US$4.8 billion in 2023, stood

UCLA, Rutgers, and Manhattan School of Music are Among the Winners of the Kaltura Digital Engagement Awards in Education 2025 Announced at Kaltura Connect in Education 2025, which showcased forward-thinking uses of AI and video in education, the awards recognize educators and institutions advancing digital engagement, accessibility, and personalization through Kaltura's AI Video Campus solutions

Faster Guest Entry at Korea's INSPIRE Entertainment Resort's Casino, Powered by Regula's Technology GlobeNewswire August 13, 2025 RESTON, Va., Aug. 13, 2025 (GLOBE NEWSWIRE) — International guests arriving at South Korea's largest foreigner-only casino, INSPIRE Entertainment Resort, now enjoy a significantly faster and more seamless check-in experience. Customer onboarding times have noticeably improved following the